+227.7%
MRNA vs PLTD
-77.3%
+305.0%
-53.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | PLTD | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.6% | +2.3% | -5.9% | -3.0% |
| 7D | -9.0% | +4.5% | -13.6% | -7.8% |
| 30D | +137.2% | -0.7% | +137.9% | +138.0% |
| 3M | +194.8% | -31.0% | +225.9% | +178.7% |
| 6M | +167.2% | -24.8% | +192.0% | +159.7% |
| YTD | +375.9% | -18.6% | +394.4% | +373.1% |
| 1Y | +465.2% | -31.8% | +497.0% | +442.5% |
| All | +227.7% | -77.3% | +305.0% | +160.2% |
Cumulative growth
Daily Returns
Daily percentage return beside PLTD.
Daily Out/Under-Performance
Portfolio return minus PLTD return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × PLTD return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded PLTD wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling